How many insider declarations does Arovella Therapeutics Limited have?

Arovella Therapeutics Limited has filed 2 insider declarations with ASX.

Who is the top reporting insider at Arovella Therapeutics Limited?

The top reporting insider at Arovella Therapeutics Limited is Andrew Nash, based on the count of public filings.

What is the net insider buy vs sell volume on Arovella Therapeutics Limited?

Across the available history, declared buys total 0 and disposals 0.

What is the ISIN of Arovella Therapeutics Limited?

The ISIN of Arovella Therapeutics Limited is AU0000182784.

InsidersTradesSigma

← Companies ★ Sign in to follow

Arovella Therapeutics Limited: management transactions · Australia · ASX

ASX:arovella-therapeutics-limitedAU0000182784AU·ASXMcap 119M€

AMF ↗

Browse the full directors' dealings record of Arovella Therapeutics Limited, a listed equity based in Australia. Shares trade on AU AU, under the oversight of ASX. Market capitalisation: €118.9m. The latest transaction was disclosed on 7 May 2026 — Other. Among the most active insiders: Andrew Nash. All data is accessible without an account.

2

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

FY ended June 2025 · cache

0.07 €

Income statement

Revenue136 k€

Gross profit136 k€100% margin

Net income−7.5 M€-5521.4% margin

Balance sheet & cash

Market cap118.9 M€

Total debt145 k€

Free Cash Flow−7.3 M€

Last declaration on 7 May 2026

All Executives2 Thresholds Prospectus Other

Declarations2 total

Executives●Other11ASX

A

Andrew NashDirector

ShareASX

ASX:2924-03087734-3A692891·7 May 2026

ASX ↗

Executives●Other11ASX

D

David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trustDirector

ShareASX

ASX:2924-03085488-3A692486·1 May 2026

ASX ↗

2 of 2 declarations